clofibrate and l 663536

clofibrate has been researched along with l 663536 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Burczynski, FJ; Gong, Y; Wang, G; Yan, J	1
Adair, J; Aliczki, M; Barnes, C; Goldberg, SR; Haller, J; Heishman, SJ; Justinova, Z; Lecca, S; Luchicchi, A; Mascia, P; Panlilio, LV; Pistis, M; Redhi, GH; Yasar, S	1

Other Studies

2 other study(ies) available for clofibrate and l 663536

Article	Year
Regulation of liver fatty acid binding protein expression by clofibrate in hepatoma cells. Biochemistry and cell biology = Biochimie et biologie cellulaire, 2010, Volume: 88, Issue:6 Topics: Anilides; Animals; Carcinoma, Hepatocellular; Catalase; Cell Line, Tumor; Clofibrate; Fatty Acid-Binding Proteins; Fluoresceins; Gene Expression Regulation, Neoplastic; Glutathione Peroxidase; Hepatocytes; Humans; Hydrogen Peroxide; Indoles; Liver Neoplasms; Oxidative Stress; PPAR alpha; Rats; RNA Stability; RNA, Messenger; Superoxide Dismutase	2010
Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:8 Topics: Action Potentials; Animals; Clofibrate; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Hypolipidemic Agents; Indoles; Male; Neurons; Nicotine; Nucleus Accumbens; PPAR alpha; Rats; Rats, Sprague-Dawley; Reward; Saimiri; Secondary Prevention; Self Administration; Tobacco Use Disorder; Ventral Tegmental Area	2012

Article

Year

Regulation of liver fatty acid binding protein expression by clofibrate in hepatoma cells.

Biochemistry and cell biology = Biochimie et biologie cellulaire, 2010, Volume: 88, Issue:6

Topics: Anilides; Animals; Carcinoma, Hepatocellular; Catalase; Cell Line, Tumor; Clofibrate; Fatty Acid-Binding Proteins; Fluoresceins; Gene Expression Regulation, Neoplastic; Glutathione Peroxidase; Hepatocytes; Humans; Hydrogen Peroxide; Indoles; Liver Neoplasms; Oxidative Stress; PPAR alpha; Rats; RNA Stability; RNA, Messenger; Superoxide Dismutase

2010

Novel use of a lipid-lowering fibrate medication to prevent nicotine reward and relapse: preclinical findings.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012, Volume: 37, Issue:8

Topics: Action Potentials; Animals; Clofibrate; Disease Models, Animal; Dopamine; Drug Evaluation, Preclinical; Hypolipidemic Agents; Indoles; Male; Neurons; Nicotine; Nucleus Accumbens; PPAR alpha; Rats; Rats, Sprague-Dawley; Reward; Saimiri; Secondary Prevention; Self Administration; Tobacco Use Disorder; Ventral Tegmental Area

2012